ANGIODYNAMICS INC — Director's Dealing 2016

Apr 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2016-04-04

Reporting Person: Clemmer James C (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-04	Common Stock	A	50000	—	Acquired	50000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-04	Non-Qualified Stock Option (right to buy)	$12.14	A	200000	Acquired	2023-04-04	Common Stock (200000)	Direct
2016-04-04	Performance Right	$	A	250000	Acquired		Common Stock (250000)	Direct

Footnotes

F1: The acquisition of 50,000 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 50,000 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on April 4, 2017, such that 25% of the restricted stock units will vest on each of April 4, 2017, 2018, 2019 and 2020.

F2: These stock options vest in four equal annual installments beginning on April 4, 2017, such that 25% of the options will vest on each of April 4, 2017, 2018, 2019 and 2020.

F3: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2019. Any shares that do not vest at the end of the performance period will be forfeited.